March 29, 2012 / 10:06 AM / 7 years ago

Chr Hansen main owner completes sale to Novo fund

COPENHAGEN, March 29 (Reuters) - The biggest shareholder in Danish food ingredients maker Chr. Hansen has sold a 25.7 percent stake to Novo A/S, cutting its holdings to 0.09 percent in line with a January announcement, Chr. Hansen said on Thursday.

Financiere Star 1 S.A., a fund controlled by private equity investment firm PAI Partners, sold about 35.42 million shares in Chr. Hansen Holding A/S to Novo A/S, Chr. Hansen said.

The companies had announced the deal on Jan. 11. .

Novo A/S is a foundation-owned company and the main shareholder in Danish drugmaker Novo Nordisk A/S and industrial enzymes maker Novozymes A/S.

Novo A/S said in January it aimed to be a long-term minority shareholder in Chr. Hansen and had no intention to take control of the company. (Reporting by John Acher, editing by Kristian Balsgaard Mortensen)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below